Ocular features of Behçet's disease: An international collaborative study

British Journal of Ophthalmology

Volumn 91, Issue 12, 2007, Pages 1579-1582

  Kitaichi, Nobuyoshi ^a   Miyazaki, Akiko ^a   Stanford, Miles R ^b   Chams, Hormoz ^c   Iwata, Daiju ^a   Ohno, Shigeaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEHCET DISEASE; BLINDNESS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE INFLAMMATION; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; UVEITIS; VISUAL ACUITY; VISUAL DISORDER; AFRICA; ASIA; CLASSIFICATION; COOPERATION; EUROPE; EYE DISEASE; FAR EAST; INCIDENCE; INFLAMMATION; INTERNATIONAL COOPERATION; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEX RATIO;

ADOLESCENT; ADULT; AFRICA, NORTHERN; AGE OF ONSET; AGED; ASIA, WESTERN; BEHCET SYNDROME; BLINDNESS; CHILD; CHILD, PRESCHOOL; COOPERATIVE BEHAVIOR; EUROPE; EYE DISEASES; FAR EAST; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; INTERNATIONALITY; MALE; MIDDLE AGED; PANUVEITIS; PROGNOSIS; SEX DISTRIBUTION; VISUAL ACUITY;

EID: 36749104357     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.123554     Document Type: Article

References (22)

1. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med 1999;341:1284-91.
2. Akiyama K, Numaga J, Yoshida A, et al. Statistical analysis of endogenous uveitis at Tokyo University Hospital (1998-2000). Jpn J Ophthalmol 2006;50:69-71.
3. Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6.
4. Ohno S, Aoki K, Sugiura S, et al. HL-A5 and Behçet's disease. Lancet 1973;2:1383-4.
5. Verily DH, Marr JE, Ohno S, et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213-20.
6. Al-Aboosi MM, al Salem M, Saadeh A, et al. Behçet's disease: clinical study of Jordanian patients. Int J Dermatol 1996;35:623-5.
7. Hamdan A, Mansour W, Uthman I, et al. Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 2006;25:364-7.
8. Krause I, Mader R, Sulkes J, et al. Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001;28:1033-6.
9. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60-76.
10. Mousa AR, Marafie AA, Rifai KM, et al. Behçet's disease in Kuwait, Arabia. A report of 29 cases and a review. Scand J Rheumatol 1986;15:310-32.
11. Atmaca LS. Fundus changes associated with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 1989;227:340-4.
12. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-80.
13. Nussenblatt RB. Uveitis in Behçet's disease. Int Rev Immunol 1997;14:67-79.
14. Sakamoto M, Akazawa K, Nishioka Y, et al. Prognostic factors of vision in patients with Behçet's disease Ophthalmology 1995;102:317-21.
15. Takeuchi M, Hokama H, Tsukahara R, et al. Risk and prognostic factor of poor visual outcome in Behçet's disease with ocular involvement Graefes Arch Clin Exp Ophthalmol 2005;243:1147-52.
16. Pivetti-Pezzi P, Accorinti M, La Cava M, et al. Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 1996;210:234- 8.
17. Mizushima Y. Recent research into Behçet's disease in Japan. Int J Tissue React 1988;10:59-65.
18. ISG for Behçets disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
19. O'Duffy J. Criteres proposes pour le diagnostic de la maladie de Behçet's et notes therapeutiques. Rev Med 1974;36:2371-9.
20. Bodaghi B, Gendron G, Wechsler B, et al. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol 2007;91:335-9.
21. Ohno S, Nakamura S, Hori S, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol 2004;31:1362-8.
22. Okada AA. Behçet's disease: general concepts and recent advances. Curr Opin Ophthalmol 2006;17:551-6.